Antibe Therapeutics Inc(Pre-Merger) ATBPF

RE:Wallace speaking @South Korea - Inflammation and Cancer conf

[Jefferam1]

I should note, he is speaking at the Plenary Lecture section
conference is: https://iik2018.org

"A plenary session is a session of a conference which all members of all parties are to attend. Such a session may include a broad range of content, from keynotes to panel discussions, and is not necessarily related to a specific style of presentation or deliberative process."

This conference is all about the GUT, Inflamaton and Cancer.

Everyone will hear him talk about ATB-346 and how he's solved the GI toxicty problem with NSAIDS.

This will be huge for spreading the word about ATB-346 to the medical community.
Talk about great timing.

Here is the focus of the conference:
On behalf of the Korean Society of Gastrointestinal Cancer (KSGC), we invite you to the IASGO, ICUR and KSGC Joint Symposium which will be held in Seoul, Korea on March 22 – 24, 2018. 

Last year, we successfully held the joint symposium with IASGO, in which we could offer recent advances in digestive oncology with distinguished experts’ talk. Especially, we could make a strong cooperation between surgeons, gastroenterologists and medical oncologists through such a great symposium. We are sure that our collaboration will be the corner stone for a multidisciplinary team approach for the management of GI cancer. 

At present, KSGC is planning to hold another joint symposium with IASGO and ICUR. ICUR is a highly well-known network for inflammation and ulcer related disease. Considering one of the most important issues in oncology is inflammation, this joint symposium with ICUR can be an important chance to broaden the understanding of GI cancers. This year, the main theme of the joint symposium is “inflammation and cancer”. We’re looking forward to organizing an international network of academic professionals in the field of digestive oncology and would greatly appreciate your participation.